newsfilter
← Latest News
Business Wire·

CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance

CM Life Sciences and merger partner Sema4 remain committed to closing transaction as soon as practicable and expect to file proxy statement in next several days CM Life Sciences, Inc. (NASDAQ:CMLF) today announced that it has filed with the Securiti